Literature DB >> 30536322

Relationship between Hashimoto's thyroiditis and papillary thyroid carcinoma in children and adolescents.

R Zeng1, M Zhao, H Niu, K-X Yang, T Shou, G-Q Zhang, X-M Yan.   

Abstract

OBJECTIVE: We investigated the relationship between Hashimoto's thyroiditis (HT) and papillary thyroid carcinoma (PTC) in children and adolescents. PATIENTS AND METHODS: We carried out a retrospective study of thyroidectomies performed from 2004 to 2017 at The First People's Hospital and the Tumor Hospital of Yunnan Province (Kunming, China). The occurrence and features of PTC and benign thyroid disease (BTD) in children and adolescents (age ≤ 20 years) were compared.
RESULTS: We evaluated 258 consecutive thyroidectomies. Among children and adolescents with PTC, 23 cases were histopathologically confirmed as HT. Mean tumor diameter was smaller in children and adolescents with PTC than in those with BTD. Thyroid-stimulating hormone (TSH) level was abnormally elevated in a greater proportion of children and adolescents with PTC as compared to those with BTD or youths with PTC. The proportion of thyroglobulin antibody (TGAb)- and thyroid peroxidase antibody (TpoAb)-positive children and adolescents was higher in the PTC than in the BTD group. Among children and adolescents with PTC, 23 had HT as compared to two in the BTD group. The proportion of children/adolescents with abnormally elevated TSH levels was higher for the PTC combined with HT group than for the PTC without HT group. A multivariate conditional logistic regression analysis showed that elevated TGAb was an independent risk factor for PTC in children and adolescents.
CONCLUSIONS: HT is associated with an increased occurrence of PTC in children and adolescents.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30536322     DOI: 10.26355/eurrev_201811_16401

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  7 in total

1.  Association between Hashimoto thyroiditis and clinical outcomes of papillary thyroid carcinoma: A meta-analysis.

Authors:  Qizhi Tang; Weiyu Pan; Liangyue Peng
Journal:  PLoS One       Date:  2022-06-16       Impact factor: 3.752

2.  Relationship Between Thyroid Autoantibodies and Recurrence of Papillary Thyroid Carcinoma in Children and Adolescents.

Authors:  Dongmei Huang; Jingtai Zhi; Jinming Zhang; Xuan Qin; Jingzhu Zhao; Xiangqian Zheng; Ming Gao
Journal:  Front Oncol       Date:  2022-06-08       Impact factor: 5.738

3.  AATF and SMARCA2 are associated with thyroid volume in Hashimoto's thyroiditis patients.

Authors:  Luka Brčić; Ana Barić; Benjamin Benzon; Marko Brekalo; Sanda Gračan; Dean Kaličanin; Veselin Škrabić; Tatijana Zemunik; Maja Barbalić; Ivana Novak; Valdi Pešutić Pisac; Ante Punda; Vesna Boraska Perica
Journal:  Sci Rep       Date:  2020-02-04       Impact factor: 4.379

4.  DNA repair proteins may differentiate papillary thyroid cancer from chronic lymphocytic thyroiditis and nodular colloidal goiter.

Authors:  Bahri Evren; Sami Yılmaz; Neşe Karadağ; Ayşe Çıkım Sertkaya; Ömercan Topaloğlu; Faruk Kılınç
Journal:  Sci Rep       Date:  2021-05-11       Impact factor: 4.379

5.  T cell exhaustion is associated with the risk of papillary thyroid carcinoma and can be a predictive and sensitive biomarker for diagnosis.

Authors:  Chumeng Zhu; Yuechu Dai; Hui Zhang; Yanyun Ruan; Yong Zhou; Yingjie Dai; Lilong Fan; Tianjun Jia; Hongsheng Lu; Qi Chen
Journal:  Diagn Pathol       Date:  2021-08-31       Impact factor: 2.644

6.  Identification of Long Noncoding RNAs Associated With the Clinicopathological Features of Papillary Thyroid Carcinoma Complicated With Hashimoto's Thyroiditis.

Authors:  Yu Zhang; Kai-Ning Lu; Jin-Wang Ding; You Peng; Gang Pan; Li-Song Teng; Ding-Cun Luo
Journal:  Front Oncol       Date:  2022-03-11       Impact factor: 6.244

7.  Diagnostic Efficacy of Ultrasound, Cytology, and BRAFV600E Mutation Analysis and Their Combined Use in Thyroid Nodule Screening for Papillary Thyroid Microcarcinoma.

Authors:  Jing Du; Ruijun Han; Cui Chen; Xiaowei Ma; Yuling Shen; Jun Chen; Fenghua Li
Journal:  Front Oncol       Date:  2022-01-03       Impact factor: 6.244

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.